Condition
Complement-mediated Kidney Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Complement-mediated Kidney Disease clinical trials that are recruiting, at sites in 9 countries (most in China (1), Australia (1), Hong Kong (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 9Countries
All recruiting trials (2)
-
CMS-D017 capsules: single and multiple dose testing in healthy adults
This trial will test CMS-D017 capsules in healthy Chinese adults to see if single and multiple oral doses are safe and how the drug behaves in the body.
-
ADX-038 treatment for adults with complement-mediated kidney disease.
This trial will test whether ADX-038 is safe and helps adults with complement-mediated kidney diseases such as IgA nephropathy, C3G, and IC-MPGN.
Related topics
Quick answers
How many Complement-mediated Kidney Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in China (1 trial), Australia (1 trial), Hong Kong (1 trial), Italy (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.